
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Growth: Good revenue growth. With NA% growth over past three years, the company is going strong.
Momentum: Stock price has a strong positive momentum. Stock is up 4.1% in last 30 days.
Insider Trading: There's significant insider buying recently.
Balance Sheet: Strong Balance Sheet.
No major cons observed.
Valuation | |
|---|---|
| Market Cap | 2.81 kCr |
| Price/Earnings (Trailing) | 31.01 |
| Price/Sales (Trailing) | 3.05 |
| EV/EBITDA | 15.41 |
| Price/Free Cashflow | 45.26 |
| MarketCap/EBT | 34.99 |
| Enterprise Value | 2.76 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 923.24 Cr |
| Rev. Growth (Yr) | 23.7% |
| Earnings (TTM) | 89.31 Cr |
| Earnings Growth (Yr) | 152.3% |
Profitability | |
|---|---|
| Operating Margin | 11% |
| EBT Margin | 9% |
| Return on Equity | 9.54% |
| Return on Assets | 3.97% |
| Free Cashflow Yield | 2.21% |
Growth & Returns | |
|---|---|
| Price Change 1W | 9.2% |
| Price Change 1M | 4.1% |
| Price Change 6M | -23.7% |
| Price Change 1Y | -13.7% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -159.63 Cr |
| Cash Flow from Operations (TTM) | 118.03 Cr |
| Cash Flow from Financing (TTM) | 11.88 Cr |
| Cash & Equivalents | 54.63 Cr |
Balance Sheet | |
|---|---|
| Total Assets | 1.37 kCr |
| Total Liabilities | 520.06 Cr |
| Shareholder Equity | 852.4 Cr |
| Current Assets | 585.18 Cr |
| Current Liabilities | 437.64 Cr |
| Net PPE | 43.48 Cr |
| Inventory | 0.00 |
| Goodwill | 351.44 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.17 |
| Debt/Equity | 0.41 |
| Interest Coverage | 2.28 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend Yield | 0.73% |
| Shares Dilution (1Y) | 5.8% |
Growth: Good revenue growth. With NA% growth over past three years, the company is going strong.
Momentum: Stock price has a strong positive momentum. Stock is up 4.1% in last 30 days.
Insider Trading: There's significant insider buying recently.
Balance Sheet: Strong Balance Sheet.
No major cons observed.
Investor Care | |
|---|---|
| Dividend Yield | 0.73% |
| Shares Dilution (1Y) | 5.8% |
| Earnings/Share (TTM) | 12.15 |
Financial Health | |
|---|---|
| Current Ratio | 0.98 |
| Debt/Equity | 0.41 |
Technical Indicators | |
|---|---|
| RSI (14d) | 53.09 |
| RSI (5d) | 92.05 |
| RSI (21d) | 59.84 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Sell |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal | Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Medi Assist Healthcare Services's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Medi Assist Healthcare Services Limited provided an optimistic outlook during their Q3 and 9 Months FY '26 earnings call. Key highlights included a 24% growth in revenue for the period and a debt-free balance sheet as of January 2026. The total income for Q3 grew 9.2% year-on-year (29.9% including Paramount), while consolidated total income for the nine months increased by 23.5%. EBITDA for Q3 reached INR 44.9 crores (consolidated EBITDA at about INR 44.6 crores). The company's margins saw a notable expansion of 154 basis points quarter-on-quarter, with an adjusted PAT of INR 34.8 crores, reflecting strong operational performance.
Management shared several forward-looking points, including:
Looking ahead, management anticipates a stronger performance as operational integrations progress and technology deployments expand, coupled with the expected recovery in retail contributions, expected to stabilize over the next quarters.
Question 1: "How do you see Medi Assist balancing between expanding partnerships with insurers, improving service delivery for customers, and protecting profits?"
Answer: I appreciate your question. At Medi Assist, we prioritize working with all insurers to enhance health insurance accessibility. We are focused on being the best service provider across various formats while ramping up efficiency and economics. The shift toward outpatient claims requires recalibration of our service and tech models. Our 94% retention rate highlights our commitment to service quality. We aim for growth that is not unilateral but fosters an increase in market share and improved access for all.
Question 2: "Which financial signals will guide your decision on cost control and investment across digital infrastructure?"
Answer: We believe in perfectly executing back-end management of claims processing. As a debt-free entity now, we are poised to judiciously invest in services that improve customer experiences. Maintaining focus on tech, especially with high-margin SaaS revenue drivers, is crucial for enhancing EBITDA. Our goal is to construct a sustainable business model for all stakeholders"”insurers, hospitals, and customers"”while driving down costs.
Question 3: "What is the update on the sluggishness in retail premium growth and when can we expect recovery?"
Answer: Retail premium fluctuations occur periodically, taking about 2-3 quarters to level out. However, our share of no-allocation portfolios has increased to 45%. The landscape is shifting toward hybrid models, combining traditional and tech-led offerings. This evolution will transform our retail approach and we anticipate gradual improvement as more hybrid strategies are adopted over time.
Question 4: "What are the details behind the exceptional item of INR 7.1 crores, and how are we preventing similar situations in the future?"
Answer: The exceptional item of INR 7.1 crores stems from a claim disallowed by an insurance customer. Though we've advanced that amount for reconciliation, we're confident it was not a standard error in our processes. We are bolstering our internal controls and audits to catch discrepancies early and avoid similar occurrences in the future.
Question 5: "What steps are you taking regarding negative ratings related to claim processing times?"
Answer: We understand the significance of customer feedback and strive for top-quality service. We process millions of claims efficiently and publish operational metrics transparently. While we acknowledge some customers face challenges, our 94% retention rate underscores our ability to meet corporate clients' expectations. We need to engage more proactively with dissatisfied customers to enhance their experience further.
Understand Medi Assist Healthcare Services ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Hdfc Large And Mid Cap Fund | 8.78% |
| ICICI Prudential Banking And Financial Services Fund | 7.46% |
| Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Elss Tax Saver Fund | 7.06% |
| Goldman Sachs Funds - Goldman Sachs India Equity Portfolio | 5.19% |
| Kotak Small Cap Fund | 4.98% |
| Medimatter Health Management Private Limited | 4.61% |
| Massachusetts Institute Of Technology | 3.87% |
| Wasatch Emerging India Fund | 3.54% |
| Aditya Birla Sun Life Insurance Company Limited | 3.5% |
| Novo Holdings A/S | 3.41% |
| Canara Robeco Mutual Fund A/C Canara Robeco Elss Tax Saver | 2.86% |
| Sundaram Mutual Fund A/C Sundaram Services Fund | 2.85% |
| 360 One Special Opportunities Fund - Series 9 | 2.73% |
| Eastspring Investments India Consumer Equity Open Limited | 1.96% |
| Old Bridge Focused Fund | 1.42% |
| Ntasain Discovery Master Fund | 1.4% |
| Sbi General Insurance Company Limited | 1.22% |
| 238 Plan Associates LLC | 1.09% |
| 360 One Special Opportunities Fund - Series 10 | 1.01% |
| Trust (Employees) | 0.01% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Medi Assist Healthcare Services against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | Apollo Hospitals Enterprises | 1.16 LCr | 24.42 kCr | +9.40% | +18.20% | 64.61 | 4.77 | - | - |
| ICICIGI | ICICI Lombard General Insurance Co. | 96.74 kCr | - | +4.40% | +2.00% | - | - | - | - |
| FORTIS | Fortis Healthcare | 71.9 kCr | 8.84 kCr | +13.30% | +43.70% | 74.87 | 8.14 | - | - |
| NIACL | The New India Assurance Co. | 30.19 kCr | - | +25.40% | -0.60% | - | - | - | - |
| STARHEALTH | Star Health and Allied Insurance Co. | 28.14 kCr | - | +10.70% | +46.50% | - | - | - | - |
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. The company offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector. It also provides pre-policy check-up and other allied services to insurance companies; and policy administration services to governments to enable public health schemes. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.